Literature DB >> 11950114

Seasonal prevalence of anti-Japanese encephalitis virus antibody in pigs in different regions of Taiwan.

K J Chang1.   

Abstract

Although the endemic season of Japanese encephalitis lasts from May through October, sporadic cases occur in other months of the year. To appreciate the real situation of Japanese encephalitis virus (JEV) activity throughout the year, a survey was conducted using hemagglutination-inhibition test to detect the presence of anti-JEV antibodies in pigs' sera, which were collected from 4 regions of Taiwan between January 2000 and January 2001. Results indicate that (1) JEV-infected pigs were found throughout the year; (2) the prevalence rates of JEV in the 4 regions in descending order were 70% in Miaoli, 59% in Hualien, 52% in Pingtung, and 49% in Nantou; (3) similar to that in 1990, the peak endemic months appeared 1 month after the date of 50% seroconversion (May 21, 2000); (4) infected pigs were present during the period from December through April as a reservoir for over-wintering of JEV; and (5) there was a suggestive evidence for the occurrence of sporadic cases of JEV during the December-April period. In conclusion, JEV propagates and is active indigenously in the winter as well as other seasons of the year.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950114

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  2 in total

1.  Development and evaluation of indirect ELISA for the detection of antibodies against Japanese encephalitis virus in swine.

Authors:  Dong Kun Yang; Byoung Han Kim; Seong In Lim; Jun Hun Kwon; Kyung Woo Lee; Cheong Up Choi; Chang Hee Kweon
Journal:  J Vet Sci       Date:  2006-09       Impact factor: 1.672

2.  The seroprevalence of Japanese encephalitis virus in goats raised in Korea.

Authors:  Dong-Kun Yang; Chang-Hee Kweon; Byoung-Han Kim; In-Jin Hwang; Mun-Il Kang; Byung-Jae So; Kyoung-Oh Cho
Journal:  J Vet Sci       Date:  2007-06       Impact factor: 1.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.